NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles


DNA-editing method shows promise to treat mouse model of progeria

Using a recently developed DNA base-editing technique, researchers correct accelerating aging disorder. Read More


Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19

The Phase 2/3 clinical trial will evaluate experimental antibodies BRII-196 and BRII-198.  Read More


Peer-reviewed report on Moderna COVID-19 vaccine publishes

Data from Phase 3 clinical trial confirm vaccine is effective. Read More


Higher red cell transfusion threshold offers no advantage for treating preterm infants

Very low birthweight infants often need blood transfusions to survive. Read More


NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness. Read More


Phase 3 trial of Novavax investigational COVID-19 vaccine opens

NIH- and BARDA-funded trial will enroll up to 30,000 volunteers. Read More


Study links metabolic syndrome to higher cardiovascular risk in patients with psoriasis

Metabolic syndrome affects about 25% of adults and is on the rise, and its prevalence is even greater among patients with psoriasis. Read More


Scientists discover how our brains track where we and others go

NIH-funded study suggests our brains may be more in tune with each other than we think. Read More


AI-designed serotonin sensor may help scientists study sleep and mental health

NIH BRAIN Initiative scientists used machine learning to redesign a bacterial ‘Venus flytrap’ protein that can monitor brain serotonin levels in real time. Read More


Infant opioid withdrawal therapy varies widely by treatment site

NIH-funded findings highlight need for clinical trials to determine best treatment options. Read More